Clonal evolution in inherited marrow failure syndromes predicts disease progression

Area of Science:

• Hematology
• Genetics
• Oncology

Background:

• Inherited bone marrow failure syndromes (IBMFS) and myelodysplastic syndromes (MDS) predisposition carry a significant risk of progression to acute myeloid leukemia (AML).
• Lack of reliable predictive markers for leukemic transformation causes patient and provider anxiety.
• Recent research highlights the role of acquired somatic mutations in assessing this risk.

Approach:

• This review synthesizes recent findings on somatic mutations in the context of inherited bone marrow failure and MDS-predisposition syndromes.
• It examines the biological mechanisms underlying these mutations, including maladaptive changes (e.g., monosomy 7) and protective genetic rescue.
• The interpretation of syndrome-specific mutation patterns and their correlation with clonal hematopoiesis is discussed.

Key Points:

• Maladaptive genetic mechanisms, such as monosomy 7, are linked to a higher risk of leukemogenesis.
• Somatic genetic rescue mutations may mitigate the risk of developing leukemia.
• Shared mutations with age-acquired clonal hematopoiesis present syndrome-specific patterns, aiding in risk stratification.

Conclusions:

• Acquired somatic mutations offer valuable insights into predicting leukemic progression in patients with inherited bone marrow failure and MDS-predisposition syndromes.
• Understanding these genetic alterations can help alleviate patient anxiety by providing clearer risk assessments.
• This knowledge supports informed patient care decisions and personalized risk management strategies.